GX-19 is a COVID-19 vaccine candidate developed by Genexine consortium.
It is a DNA-based vaccine that encodes the SARS-CoV-2 spike protein.
References
GX-19 is a COVID-19 vaccine candidate developed by Genexine consortium.
It is a DNA-based vaccine that encodes the SARS-CoV-2 spike protein.
